Inventor · disambiguated record
Nicolas Manel
Also filed as: MANEL NICOLAS · MANEL NICOLAS GABRIEL ALBERT
12 granted patents·7 pending applications·29 citations·filing 2003–2023
87Inventor score
Files withINST CURIE8CENTRE NAT RECH SCIENT4MANEL NICOLAS3BATTINI JEAN-LUC GEORGES LAURENT1CENTRE NAT DE LA RECH SCIENT (CNRS)1
Top patents by PatentIndex Score
19 records- 0183US8404482B2Methods for in vitro differentiation of Th-17+ cellsMANEL NICOLAS·Filed 2012·Granted Mar 26, 2013·4 cites·5 claims
- 0281US10010607B2Method for preparing viral particles with cyclic dinucleotide and use of said particles for inducing immune responseINST CURIE·Filed 2015·Granted Jul 3, 2018·6 cites·21 claims
- 0381US8183040B2Methods for in vitro differentiation of Th-17+cellsMANEL NICOLAS·Filed 2009·Granted May 22, 2012·6 cites·13 claims
- 0480US9498495B2Methods for in vitro differentiation of TH-17+ cellsMANEL NICOLAS·Filed 2013·Granted Nov 22, 2016·2 cites·12 claims
- 0576US9777044B2GLUT-1 as a receptor for HTLV envelopes and its usesCENTRE NAT DE LA RECH SCIENT (CNRS)·Filed 2014·Granted Oct 3, 2017·2 cites·17 claims
- 0668US9358281B2Methods, agents and peptides for inducing an innate immune response in HIV vaccinationLITTMAN DAN·Filed 2010·Granted Jun 7, 2016·1 cites·12 claims
- 0767US8945583B2GLUT-1 as a receptor for HTLV envelopes and its usesBATTINI JEAN-LUC GEORGES LAURENT·Filed 2009·Granted Feb 3, 2015·2 cites·18 claims
- 0866US7642061B2Glut-1 as a receptor for HTLV envelopes and its usesCENTRE NAT RECH SCIENT·Filed 2004·Granted Jan 5, 2010·4 cites·14 claims
- 0966US2025213614A1Modified RELA Protein for Inducing Interferon Expression and Engineered Immune Cells with Improved Interferon ExpressionINST CURIE·Filed 2023·Application pending·0 cites
- 1062US7507529B2Oligonucleotides originating from sequences coding for the surface component of PTLV envelope proteins and their usesCENTRE NAT RECH SCIENT·Filed 2003·Granted Mar 24, 2009·2 cites·15 claims
- 1162US2025304915A1Myeloid Cells Overexpressing BCL2INST CURIE·Filed 2022·Application pending·0 cites
- 1261US2024423927A1Compositions and methods for use in immunotherapyINST CURIE·Filed 2022·Application pending·0 cites
- 1359US2024424090A1Compositions and methods for use in immunotherapyINST CURIE·Filed 2022·Application pending·0 cites
- 1455US2018002383A1Glut-1 as a receptor for htlv envelopes and its usesCENTRE NAT RECH SCIENT·Filed 2017·Application pending·0 cites
- 1553US7947452B2Oligonucleotides originating from sequences coding for the surface component of PTLV envelope proteins and their usesCENTRE NAT RECH SCIENT·Filed 2009·Granted May 24, 2011·0 cites·17 claims
- 1648US2018296667A1Method for preparing viral particles with cyclic dinucleotide and use of said particles for inducing immune responseINST CURIE·Filed 2018·Application pending·0 cites
- 1737US10969389B2Method to monitor and quantify interphase nuclear envelope rupture eventsINST CURIE·Filed 2017·Granted Apr 6, 2021·0 cites·7 claims
- 1836US9505798B2Steroid compounds as RORyt modulators and uses thereofLITTMAN DAN R·Filed 2011·Granted Nov 29, 2016·0 cites·17 claims
- 1930US2019105381A1Method for preparing viral particles with cyclic dinucleotide and use of said particles for treating cancerINST CURIE·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicolas Manel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →